Clinical activity of osimertinib in EGFR mutation positive non-small cell lung cancer (NSCLC) patients (pts) previously treated with rociletinib Meeting Abstract


Authors: Gadgeel, S.; Chen, W.; Piotrowska, Z.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Varga, A.; Yu, H.; Papadimitrakopoulou, V.; Nea, J.; Soria, J. C.; Wozniak, A.; Riely, G.; Narayanan, V.; Mendenhal, M.; Sequist, L.
Abstract Title: Clinical activity of osimertinib in EGFR mutation positive non-small cell lung cancer (NSCLC) patients (pts) previously treated with rociletinib
Meeting Title: IASLC 17th World Conference on Lung Cancer
Keywords: egfr; t790m; rociletinib; osimertinib
Journal Title: Journal of Thoracic Oncology
Volume: 12
Issue: 1 Suppl.
Meeting Dates: 2016 Dec 4-7
Meeting Location: Vienna, Austria
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2017-01-01
Start Page: S1263
Language: English
ACCESSION: WOS:000413055803032
PROVIDER: wos
DOI: 10.1016/j.jtho.2016.11.1783
Notes: Meeting Abstract: P3.02b-115 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    281 Yu
  2. Gregory J Riely
    599 Riely